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ISSObjective: To compare microbial translocation and its biomarkers in HIV-1-infected
African and White patients of the Lie`ge AIDS Reference Center.
Design: The study is based on a cross-sectional dataset of HIV-infected patients treated
at the Lie`ge AIDS Reference Center. Groups of white and African patients have been
randomly selected to be identical for sex, age and duration of treatment.
Methods: sCD14, lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP)
and routine HIV-follow-up parameters were measured on plasma samples.
Results: High values of LPS and LBP were observed in both groups of patients without
significant difference between them. High values of sCD14 were observed in 53.1% of
whites and only in 18.8% of African patients (P¼0.0042). A correlation between LPS
and sCD14 was observed in whites but not African patients.
Conclusion: Our observation suggests that factors not related tomicrobial translocation
are responsible for lower sCD14 value in Africans.
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soluble CD14Introduction
The progression of HIV disease is lead both by viral
replication and by immune activation whose intensity is
in fact is a better predictor of progression to AIDS than
virological markers [1].
It is known that HIV infection of the gut-associated
lymphoid tissue (GALT) selectively depletes CD4þ Th17
cells and subsequently impairs intestinal barrier function.
Consequently, whole bacteria and microbial products
from the intestine enter the systemic circulation, a
phenomenon called microbial translocation.e, Lie`ge, Belgium.
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possible mechanism underlying the chronic immune
activation associated with HIV infection and subsisting
despite antiretroviral therapy [2,3].
Microbial translocation is usually evaluated by measuring
blood concentration of bacterial lipopolysaccharide
(LPS). Nevertheless, measuring LPS concentration is a
technically complex process and difficult to implement in
routine care. Therefore, there is a need to identify reliable
biomarkers of microbial translocation easier to measure
than LPS itself.Belgium.
pted: 30 November 2015.
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Table 1. Comparison of the two ethnic groups (Whites vs. Africans).
White (N¼32) Black African (N¼32) P valuea
Male sex 17 (53) 15 (47) 0.62
Age (years) 4713 4610 0.16
BMI (kg/m2) 25.11.5 26.51.9 0.31
Absolute CD4þ (103 cells/ml) 0.670.25 0.550.24 0.28
Absolute CD8þ (103 cells/ml) 0.890.44 0.670.29 0.10
b2-microglobulin (mg/l) 1.503.9 0.270.48 0.74
Patients with high viral load (>200 copies/ml) 1 (1.6) 2 (3.1) 0.99b
C-reactive protein (CRP) (mg/l) 5.18.7 5.710.8 0.69
Total cholesterol (g/l) 2.20.4 2.00.51 0.58
High-density lipoprotein cholesterol (g/l) 2.810.2 2.58.1 0.42
Non-high-density lipoprotein cholesterol (g/l) 1.60.48 1.40.5 0.47
Triglycerides (g/l) 2.22.0 1.41.8 0.026
Gamma glutamyl transpeptidase (GGT) (U/l) 37.824.2 35.720.0 0.89
Glutamate-oxaloacetate transaminase (GOT) (U/l) 25.99.2 29.413.8 0.17
Glutamopyruvate transferase (GPT) (U/l) 29.822.3 30.929.5 0.39
Alcaline phosphatase (U/l) 93.032.5 84.434.8 0.44
sCD14 (ng/ml) 1939440 1756806 0.0087c
Patients with high sCD14 (2000ng/ml) 17 (53.1) 6 (18.8) 0.0042c
Lipopolysaccharides (LPS) (pg/ml) 22.812.3 20.611.6 0.53
Patients with high LPS (25.0pg/ml) 14 (43.8) 14 (43.8) 1.00
Lipopolysaccharide-binding protein (LBP) (ng/ml) 1.92.2 1.51.5 0.43
Patients with high LBP (4.1ng/ml) 5 (15.6) 2 (6.3) 0.43b
aWilcoxon rank-sum test.
bx2 test or Fisher exact test.
cIndicates in which aspects our populations are different.CD14 is a coreceptor for LPS along with toll-like
receptor-4 and myeloid differentiation factor-2 and is
bound to the membrane by a gltcosyl phosphatidylino-
sitol anchor. After exposure to bacterial endotoxin,
monocytes release soluble CD14 (sCD14) by a protease-
dependent shedding of the membrane form [4] but also
by direct secretion of the soluble form [5,6]. Hepatocytes
also produce sCD14 after LPS exposure by both
mechanisms [7]. Accordingly, the increase of sCD14
has been described in Gram– bacterial sepsis [8] but also in
other conditions associated with microbial translocation
such as insulin resistance [9], liver inflammation [10], and
cardiovascular diseases [11]. Several studies have also
shown increased levels of sCD14 in HIV-infected patients
with a good correlation with endotoxin levels [12–14]
therefore establishing sCD14 as a potential surrogate
marker for microbial translocation. Most importantly,
from a nested case–control study performed on patients
from the SMART trial, it was demonstrated that sCD14 is
an independent marker of mortality [15].
The mechanisms underlying the increase of sCD14 are
nevertheless complex as exposure to cytokines such as
interleukin 6 (IL-6) and IL-1 b is sufficient to trigger its
release [16] suggesting that it is more amarker ofmonocyte
activation than of microbial translocation. It is also known
that the exposure to IL-6 releases sCD14 by the liver [17].
Importantly, ethnicity could also be a confounding factor
weakening the link between sCD14 and microbial
translocation. Reiner et al. measured sCD14 levels in
more than 5000 non-HIV-infected individuals above 65-
year old living in the United States. Interestingly, sCD14
levels were lower in blacks. The authors estimated that
genetic factors (i.e. differences in frequencies of CD14alleles associated with its lower expression) could only
explain 23% of this difference [18]. The objective of this
study was to confirm these data in a mixed race population
of HIV-infected patients living in Belgium.Material and methods
The study was based on a sample of 64 chronically HIV-
infected patients treated at the Lie`ge AIDS Reference
Center. There were 32 whites and 32 black Africans
living in Belgium for at least 3 years (mean SD,
11.1 8.0 years) and originating from Congo (DRC),
Rwanda, Burundi, Cameroun, Ivory Coast, Guinea and
Togo. The two ethnic groups were matched by age, sex
and treatment. The Ethical Committee of the CHU of
Lie`ge approved the study protocol. Consent for
participation was obtained in accordance with institu-
tional review board standards.
Microbial translocation biomarkers
Direct [LPS and lipopolysaccharide-binding protein
(LBP)] and indirect (sCD14) markers of microbial
translocation were measured. LPS were measured using a
Human LPS ELISA kit (Cusabio,Wuhan, China). Samples
were measured according to the assay protocol. Samples
were stored at –808C (193.158K) after centrifugation. All
themeasurementswere performed in the same run. sCD14
was measured by using enzyme-linked immunosorbent
assay with the manufacturers’ protocol (R&D Systems,
Minneapolis, Minnesota, USA) on 100ml of patient’s
serum (serum diluted to 0.5%). LBP was quantified with
the manufacturers protocol (Cusabio, Wuhan, China).
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Ethnic groups were compared by theWilcoxon rank-sum
test for quantitative variables and the x2 or Fisher exact
test for qualitative findings. The Spearman correlation
coefficient was calculated to measure the association
between two quantitative variables. Calculations were
computed on the maximum of available data, none
missing values were replaced. Results were considered as
significant at the 5% critical level (P< 0.05). The analyses
were carried out using SAS (version 9.4; SAS Institute
Inc., Cary, North Carolina, USA) and R (version 3.0.3)
statistical packages.Results
The two ethnic groups were similar for BMI, CD4, CD8,
viral load, liver tests and cholesterol (Table 1). Triglycer-
ides levels were higher in whites than in black African
patients (P¼ 0.026) and so were sCD14 values
(1939 439 vs. 1756 806 ng/ml, P¼ 0.0087). High
values of sCD14 (defined by a concentration higher than
2000 ng/ml) were observed in 53.1% of whites and only
in 18.8% of black Africans (P¼ 0.0042) (Fig. 1).
In contrast, LPS concentrations did not differ significantly
between the two ethnic groups (22.8 12.3 vs.
20.6 11.6 pg/ml, P¼ 0.53) and the proportion of
patients with concentrations above 25 pg/ml was
comparable in both groups. Similarly, no difference
was found regarding LBP concentrations (1.9 2.2 vs.
1.5 1.5 ng/ml, P¼ 0.43) and proportions of patients












































Fig. 1. Markers of microbial translocation according to ethnicity
observed in 53.1% of white and in 18.8% of black ethnicity patien
cannot be considered as different (x2, P¼1.00). Proportion of patien
exact, P¼0.43). LBP, lipopolysaccharide-binding protein; LPS, lipAs expected, the correlation between LPS and LBP was
strong (r¼ 0.79) and comparable in white (r¼ 0.79) and
African patients (r¼ 0.78). Interestingly, the negative
association between LPS and sCD14 was weaker in
African patients (r¼ –0.23) than in whites (r¼ –0.38).Discussion
Microbial translocation is a central mechanism of HIV
pathogenesis as it links the tropism of the virus for
mucosal CD4þ T cells to the long-term deleterious
immune activation process associated with HIV infection.
In addition to its role as a biomarker, sCD14 is also an
actor in the inflammatory responses as it sensitizes tissues
devoid of membrane CD14 such as endothelium [19] and
platelets [20] to the effects of endotoxin. It is therefore
logical that sCD14 stands as an independent marker of
morbidity and mortality in various inflammatory
processes including HIV infection.
In our study, we confirmed that HIV-infected Black
Africans living in Belgium have lower levels of sCD14
when compared with a group of whites matched with
respect to age, sex and CD4þ cell count. Different levels
of microbial translocation could not explain this
difference as endotoxin concentrations and LBP were
similar in both groups. A recent study has shown that in
the general population above 65, sCD14 level is lower in
black Africans, a difference only partially explained by
genetics [18]. It is interesting to note that this also holds
true in a younger population of HIV-infected individuals
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associated with higher sCD14 levels in HIV-infected
individuals [21]. In our study, the proportion of current
smokers was indeed higher in Europeans than in black
Africans. Different enterotypes, influenced by long-term
dietary habits, could also intervene as the composition of
intestinal microbiome also influences sCD14 levels in the
context of HIV infection [22]. IL-6 is directly involved in
the upregulation of sCD14 [16,17]. Interestingly, in
untreated HIV-infected patients, IL-6 concentrations are
lower in blacks than in whites [23]. As CRP levels were
similar in our groups of treated patients, we do not
believe that a difference in the concentration of IL-6
could explain our observation. Finally, it is interesting to
note that association between LPS and sCD14 concen-
trations is weaker in the black African patients,
confirming that sCD14 is not a direct marker of
microbial translocation and that confounding factors,
largely influenced by environmental conditions have to
be taken into account for the interpretation of abnormal
sCD14 concentrations.Acknowledgements
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